I make a donation

A randomized controlled trial on mavacamten, a myosin inhibitor in patients with obstructive hypertrophic cardiomyopathy

Mavacamten - Hypertrophic cardiomyopathy

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Publication presented by Thibault REMY

On July 12, 2022

Title: Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

09/04/2024

SGB - Refractory Ventricular Arrhythmias - Electrical storm

02/04/2024

ACS - Dual anti platelet therapy - Ticagrelor - Aspirin

19/03/2024

Vasomotor dysfunction - ANOCA